About Digvijay Pharma Ceuticals India Private Limited
Data last updated:
Digvijay Pharma Ceuticals India Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2010PTC203751. Its GSTIN is 27AADCD4794Q1ZU (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sheetal Suresh Ghare and Mahendra Krishna Sarkale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5/504 Tulsi Vihar Co – Op. Hsg Society S.V. Road, Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.36 Lakh, a decline of 67% compared to the previous year. For the same year it recorded a net loss of ₹26,168 (net margin -1.6%) and EBITDA of ₹16,656 (EBITDA margin 1%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website digvijaypharma.com.
Company details
Contact details
Digvijay Pharma Ceuticals India Private Limited's registered office is in Thane, Maharashtra. Its website is digvijaypharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address5/504 Tulsi Vihar Co – Op. Hsg Society S.V. Road, Thane, Maharashtra, India – 400607
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Digvijay Pharma Ceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Digvijay Pharma Ceuticals India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Digvijay Pharma Ceuticals India Private Limited, buy the company report.
Financials of Digvijay Pharma Ceuticals India Private Limited
FY 2025 filings availableDigvijay Pharma Ceuticals India Private Limited reported revenue of ₹16.36 Lakh (down 67% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 67% fall in the latest year. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16,656 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26,168 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | -1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Digvijay Pharma Ceuticals India Private Limited, buy the company report.
Board of directors of Digvijay Pharma Ceuticals India Private Limited
Digvijay Pharma Ceuticals India has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sheetal Suresh Ghare Also directs: Chemcon Laboratories Private Limited | Director | 19 Apr 2018 | 8 Years 6 Months | Current |
| Mahendra Krishna Sarkale | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Sharda Vishwas Ghare Also directs: Chemcon Laboratories Private Limited | Director | 07 Jun 2010 | 16 Years 5 Months | Current |
| Vishwas Sadhu Ghare Also directs: Chemcon Laboratories Private Limited | Director | 07 Jun 2010 | 16 Years 5 Months | Current |
Auditor
Digvijay Pharma Ceuticals India Private Limited is audited by MANOJ J GUPTA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ J GUPTA & ASSOCIATES | FY 2022 | 122790W |
Shareholding
The shareholding of Digvijay Pharma Ceuticals India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Digvijay Pharma Ceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Digvijay Pharma Ceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Digvijay Pharma Ceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Digvijay Pharma Ceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCD4794Q1ZU | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Digvijay Pharma Ceuticals India Private Limited, buy the company report.
Recent activity
Digvijay Pharma Ceuticals India Private Limited has 7 board changes on record since 2010: 4 appointments and 3 cessations. The latest: Mahendra Krishna Sarkale ceased to be Additional Director on 29 Nov 2021.
Frequently asked questions
Digvijay Pharma Ceuticals India is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2010 (16+ years old) and is registered under CIN U24232MH2010PTC203751.
Digvijay Pharma Ceuticals India has 4 current directors:
- Sheetal Suresh Ghare - Director
- Mahendra Krishna Sarkale - Director
- Sharda Vishwas Ghare - Director
- Vishwas Sadhu Ghare - Director
The latest financial statements of Digvijay Pharma Ceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Digvijay Pharma Ceuticals India is 27AADCD4794Q1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Digvijay Pharma Ceuticals India is U24232MH2010PTC203751. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Digvijay Pharma Ceuticals India was incorporated on 07 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Mahendra Krishna Sarkale ceased to be Additional Director on 29 Nov 2021. Digvijay Vishwas Ghare ceased to be Additional Director on 17 Aug 2021. Mahendra Krishna Sarkale was appointed as Director on 17 Aug 2021. Digvijay Pharma Ceuticals India has 7 board changes on record in total.
Digvijay Pharma Ceuticals India can be reached through the website digvijaypharma.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Digvijay Pharma Ceuticals India is at 5504 Tulsi Vihar Co – Op. Hsg Society S.V. Road, Thane, Maharashtra, India – 400607.
Digvijay Pharma Ceuticals India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
